The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Individual PK-guided sunitinib dosing: A feasibility study in patients with advanced solid tumors.
Nienke A.G. Lankheet
No relevant relationships to disclose
Jacqueline S.L. Kloth
No relevant relationships to disclose
Christa G.M. Gadellaa-van Hooijdonk
No relevant relationships to disclose
Geert A. Cirkel
No relevant relationships to disclose
Ron H.J. Mathijssen
No relevant relationships to disclose
Martijn P.J.K. Lolkema
No relevant relationships to disclose
Jan H. M. Schellens
No relevant relationships to disclose
Emile E. Voest
No relevant relationships to disclose
Stefan Sleijfer
No relevant relationships to disclose
Jos H. Beijnen
No relevant relationships to disclose
Alwin D.R. Huitema
No relevant relationships to disclose
Neeltje Steeghs
No relevant relationships to disclose